ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Mandatory Nodal Evaluation During Resection of Clinical T1a Non-Small Cell Lung Cancers

Friday, May 6, 2022

Submitted by

Christopher Anderson

Source

Source Name: The Annals of Thoracic Surgery

Source URL: https://doi.org/10.1016/j.athoracsur.2021.06.078

Author(s)

Aaron R. Dezube, MD Emanuele Mazzola, PhD Ashley Deeb, MD Daniel C. Wiener, MD M. Blair Marshall, MD Mathew W. Rochefort, MD Michael T. Jaklitsch, MD

Recommendations for intraoperative lymph node evaluation are uniform regardless of whether a primary tumor is clinical T1a or T2a according to TNM 8th edition for stage I non-small cell lung cancer (NSCLC). We quantified nodal disease risk in patients with T1a disease (≤1 cm).